<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for CLDX</title>
    <link />
    <description>Headlines for Celldex Therapeutics, Inc.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Celldex Therapeutics' Management Presents at Credit Suisse Antibody Day Conference (Transcript)</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1427091-celldex-therapeutics-management-presents-at-credit-suisse-antibody-day-conference-transcript.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Sat, 11 May 2013 18:29:02 GMT</pubDate>
    </item>
    <item>
      <title>Predicting Biotech Stock Moves Using Top Consensus Picks By Legendary Fund Managers</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1403711-predicting-biotech-stock-moves-using-top-consensus-picks-by-legendary-fund-managers.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Sun, 05 May 2013 13:23:34 GMT</pubDate>
    </item>
    <item>
      <title>Agenus 8 Near term Data Drivers with a Market Opportunity over $17 Billion dollars</title>
      <link>http://www.fool.com/news/xt/trefis/www.trefis.com/stock/agen/articles/183432/agenus-8-near-term-data-drivers-with-a-market-opportunity-over-17-billion-dollars/2013-04-29.aspx</link>
      <author>Trefis</author>
      <pubDate>Mon, 29 Apr 2013 09:46:48 GMT</pubDate>
    </item>
    <item>
      <title>Agenus: Near-Term Drivers With A Market Opportunity Over $17 Billion</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1377581-agenus-near-term-drivers-with-a-market-opportunity-over-17-billion.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 29 Apr 2013 08:15:00 GMT</pubDate>
    </item>
    <item>
      <title>CLDX up 223%, Cohen Gains Big</title>
      <link>http://www.fool.com/news/xt/gurufocus/www.gurufocus.com/news/217269/cldx-up-223-cohen-gains-big.aspx</link>
      <author>GuruFocus</author>
      <pubDate>Tue, 23 Apr 2013 20:14:40 GMT</pubDate>
    </item>
    <item>
      <title>CLDX up 223%, Cohen Gains Big</title>
      <link>http://www.fool.com/news/xt/nasdaq/www.nasdaq.com/article/cldx-up-223-cohen-gains-big-cm239841.aspx</link>
      <author>Nasdaq</author>
      <pubDate>Tue, 23 Apr 2013 19:10:20 GMT</pubDate>
    </item>
    <item>
      <title>Melanoma: Battle Of 3 Cancer Vaccines</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1362181-melanoma-battle-of-3-cancer-vaccines.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 23 Apr 2013 13:25:30 GMT</pubDate>
    </item>
    <item>
      <title>5 Stocks Poised for Breakouts</title>
      <link>http://www.fool.com/news/xt/thestreet/www.stockpickr.com/5-stocks-poised-breakouts.html-30.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Fri, 19 Apr 2013 14:13:00 GMT</pubDate>
    </item>
    <item>
      <title>3 Biotechs Targeting Breast Cancer</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1351181-3-biotechs-targeting-breast-cancer.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 18 Apr 2013 11:49:33 GMT</pubDate>
    </item>
    <item>
      <title>Celldex Presents Data on CDX-1127, Says Elicits Potent Activation of Cells, Says Complement to Ongoi</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/04/3479303/celldex-presents-data-on-cdx-1127-says-elicits-potent-activation-of-cells-says-co.aspx</link>
      <author>Benzinga</author>
      <pubDate>Mon, 08 Apr 2013 13:04:24 GMT</pubDate>
    </item>
    <item>
      <title>Steve Cohen Increases Celldex Up 145%</title>
      <link>http://www.fool.com/news/xt/gurufocus/www.gurufocus.com/news/215803/steve-cohen-increases-celldex-up-145.aspx</link>
      <author>GuruFocus</author>
      <pubDate>Sat, 06 Apr 2013 15:31:08 GMT</pubDate>
    </item>
    <item>
      <title>Steve Cohen Increases Celldex Up 145%</title>
      <link>http://www.fool.com/news/xt/nasdaq/www.nasdaq.com/article/steve-cohen-increases-celldex-up-145-cm234341.aspx</link>
      <author>Nasdaq</author>
      <pubDate>Sat, 06 Apr 2013 14:05:58 GMT</pubDate>
    </item>
    <item>
      <title>Survival Strategies For Development Biotechs And How They Affect Share Prices</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1306711-survival-strategies-for-development-biotechs-and-how-they-affect-share-prices.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 28 Mar 2013 10:42:09 GMT</pubDate>
    </item>
    <item>
      <title>Vaccinate Your Portfolio with These 3 Drugmakers</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/21/vaccinate-your-portfolio-with-these-3-drugmakers/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 21 Mar 2013 10:33:00 GMT</pubDate>
    </item>
    <item>
      <title>What's Going On With Celldex?</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1272471-what-s-going-on-with-celldex.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 14 Mar 2013 03:04:07 GMT</pubDate>
    </item>
    <item>
      <title>Encouraging Data Presented by Gilead - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/94558/encouraging-data-presented-by-gilead.aspx</link>
      <author>Zacks</author>
      <pubDate>Tue, 12 Mar 2013 13:50:01 GMT</pubDate>
    </item>
    <item>
      <title>UPDATE: Wedbush Raises PT to $8 on Celldex Therapeutics on Rindopepimut Outlook</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/13/03/3409513/update-wedbush-raises-pt-to-8-on-celldex-therapeutics-on.aspx</link>
      <author>Benzinga</author>
      <pubDate>Tue, 12 Mar 2013 13:30:45 GMT</pubDate>
    </item>
    <item>
      <title>Pharmacyclics to Sell Shares - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/94474/pharmacyclics-to-sell-shares.aspx</link>
      <author>Zacks</author>
      <pubDate>Mon, 11 Mar 2013 16:00:01 GMT</pubDate>
    </item>
    <item>
      <title>Santarus Tops, Focus on Zegerid - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/94455/santarus-tops-focus-on-zegerid.aspx</link>
      <author>Zacks</author>
      <pubDate>Mon, 11 Mar 2013 14:04:01 GMT</pubDate>
    </item>
    <item>
      <title>What Is Driving Celldex Therapeutics' Share Value?</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1262901-what-is-driving-celldex-therapeutics-share-value.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 11 Mar 2013 11:15:16 GMT</pubDate>
    </item>
  </channel>
</rss>
